Arrowhead Pharmaceuticals, Inc. (0HI3.L) LSE

20.16

+0.0326(+0.16%)

Updated at August 18 06:30PM

Currency In USD

Valuation

Market Cap2.32B
Enterprise Value2.73B
P/E Ratio-18.65
PEG Ratio-2.16
Price/Sales Ratio4.61
Price/Book Ratio5.33
Enterprise/Revenue4.59
Enterprise/EBITDA-39.32

Fiscal Year

Fiscal YearSeptember 30, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.25
Operating Margin-0.18

Management Effectiveness

Return On Assets-0.11
Return On Equity-0.41

Income Statement

Revenue3.55M
Revenue/Share4.29
Gross Profit3.55M
EBITDA-561.51M
Net Income-599.49M
Diluted EPS-5

Balance Sheet

Total Cash900.37M
Total Cash/Share6.48
Total Debt112.7M
Total Debt/Equity0.22
Current Ratio4.87
Book Value Per Share5.14

Price History

52-Week Change-12.48
52-Week High41.86
52-Week Low20.04
Moving Average 50 Days32.83
Moving Average 200 Days31.06

Statistics

Average Volume1,779
Shares Outstanding138.27M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A